Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

186
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
186
Teratogenicity01:07

Teratogenicity

2.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial frequency processing preferentially recruits distributed cortical interactions in V1.

Neuroreport·2026
Same author

Gestational weight gain and birth outcomes in a large Canadian cohort of pregnant persons with inflammatory bowel disease.

Crohn's & colitis 360·2026
Same author

Machine Perfusion Preservation Highlights From the Congress of the European Society of Organ Transplantation 2025.

Artificial organs·2026
Same author

Eye Dominance and Testing Order Effects in the Circularly-Oriented Macular Pigment Optical Density Measurements.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026
Same author

Maternal attention deficit hyperactivity disorder and adverse obstetrical and perinatal outcomes: A population-based cohort study in Ontario, Canada.

American journal of obstetrics & gynecology MFM·2026
Same author

Assessing the impact of delivery method on severe maternal morbidity among individuals with inflammatory bowel disease: a population-based study.

Journal of Crohn's & colitis·2026
Same journal

Internalization-Dependent EGFR-Targeted Photoactivation by Cetuximab-I21 Conjugates.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Same journal

Clinical Features, Treatment, and Outcomes of Nivolumab-induced Autoimmune Hemolytic Anemia.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Same journal

Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Same journal

Ligand-Receptor-Based Novel TWEAK CAR-T Exhibits Potent Antitumor Activity Against Liver Cancer by Targeting FN14.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Same journal

Talimogene Laherparepvec Response in Recurrent Melanoma During Corticosteroid Replacement for Immune Checkpoint Inhibitor-Induced Adrenal Insufficiency: A Case Report.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Same journal

Pulsed Electrical Field Ablation Plus Intratumoral Immunotherapy for Hepatocellular Carcinoma.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
See all related articles

Related Experiment Video

Updated: Sep 28, 2025

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

1.8K

Immune Checkpoint Inhibitor Exposure in Pregnancy: A Scoping Review.

Iman Salehi1, Ludmila Porto2, Christine Elser3

  • 1Mount Sinai Hospital.

Journal of Immunotherapy (Hagerstown, Md. : 1997)
|March 30, 2022
PubMed
Summary
This summary is machine-generated.

Immune checkpoint inhibitors (ICIs) used in cancer treatment may disrupt maternal immune tolerance, potentially harming the fetus. This review examines existing human pregnancy exposure cases and adds two new cases to inform clinical understanding.

More Related Videos

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

9.8K
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

17.5K

Related Experiment Videos

Last Updated: Sep 28, 2025

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

1.8K
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

9.8K
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

17.5K

Area of Science:

  • Oncology
  • Immunology
  • Reproductive Medicine

Background:

  • Immune checkpoint inhibitors (ICIs) are standard cancer treatments blocking T-cell regulation pathways.
  • These pathways, including PD-1/PD-L1 and CTLA-4, are crucial for maternal immune tolerance during pregnancy.
  • Disruption of these pathways by ICIs could trigger maternal immune responses against the fetus.

Observation:

  • Animal studies suggest ICIs may trigger maternal immune responses against the fetus.
  • Human data on ICI exposure during pregnancy is limited, with only 6 prior cases reported.
  • This study reviews existing literature and presents 2 new cases of maternal ICI exposure.

Findings:

  • The effects of ICIs on human pregnancy outcomes are not well-established.
  • Review of 6 prior cases and 2 new cases provides limited but important clinical data.
  • Further research is needed to understand the risks and management of ICIs in pregnant patients.

Implications:

  • Understanding ICI effects on pregnancy is critical for oncologists and patients.
  • Potential risks to fetal development require careful consideration.
  • This work contributes to a growing body of evidence on immunotherapy in pregnancy.